Tania LaGambina
Rosa Biotech accelerates NASH pre-clinical trial in liver disease
Bio-sensing pioneer secures £415,000 from angel investors Funding will accelerate non-alcoholic fatty liver disease (NAFLD / NASH)...
top of page
news
Arne Scott
- Mar 27
- 2 min
Rosa publishes founding research in Nature Communications
We are delighted to publish the founding research behind Rosa and our Pandra platform in Nature Communications. The paper - a...
280 views0 comments
bottom of page